Metabolomic Technologies Company
Metabolomic Technologies develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
Founded Date:
2010-01-01
Estimated Revenue:
Less than $1M
Total Funding:
4575000
Investors Number:
4
Employee Number:
11-50
Last Funding Type:
Series A
Industry:
Anti-aging Therapies
Headquarters:
Edmonton, Alberta, Canada
Funding Status:
Early Stage Venture
Last Funding Date:
2019-10-22